과제정보
This paper was supported by Wonkwang Health Science University in 2024.
참고문헌
- Inker LA, Coresh J, Levey AS, Tonelli M, Muntner P. Estimated GFR, albuminuria, and complications of chronic kidney disease. J Am Soc Nephrol. 2011;22:2322-2331. https://doi.org/10.1681/ASN.2010111181
- Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2020;98(4S): S1-S115. https://doi.org/10.1016/j.kint.2020.06.019
- Kuo IC, Lin HY, Niu SW, Lee JJ, Chiu YW, Hung CC, et al. Anemia modifies the prognostic value of glycated hemoglobin in patients with diabetic chronic kidney disease. PLoS One. 2018;13:e0199378. https://doi.org/10.1371/journal.pone.0199378
- Kubo K, Okamura T, Sugiyama D, Hisamatsu T, Hirata A, Kadota A, et al. Effect of chronic kidney disease or anemia or both on cardiovascular mortality in a 25-year follow-up study of Japanese general population (from NIPPON DATA90). Am J Cardiol. 2022;184:1-6. https://doi.org/10.1016/j.amjcard.2022.08.027
- Bajaj S, Makkar BM, Abichandani VK, Talwalkar PG, Saboo B, Srikanta SS, et al. Management of anemia in patients with diabetic kidney disease: a consensus statement. Indian J Endocrinol Metab. 2016;20:268-281. https://doi.org/10.4103/2230-8210.176348
- Roshan B, Stanton RC. A story of microalbuminuria and diabetic nephropathy. J Nephropathol. 2013;2:234-240. https://doi.org/10.12860/JNP.2013.37
- Portoles J, Martin L, Broseta JJ, Cases A. Anemia in chronic kidney disease: from pathophysiology and current treatments, to future agents. Front Med (Lausanne). 2021;8:642296. https://doi.org/10.3389/fmed.2021.642296
- Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17-28. https://doi.org/10.1038/ki.2010.483
- Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713-735. https://doi.org/10.1053/j.ajkd.2014.01.416
- Adetunji OR, Mani H, Olujohungbe A, Abraham KA, Gill GV. 'Microalbuminuric anaemia'--the relationship between haemoglobin levels and albuminuria in diabetes. Diabetes Res Clin Pract. 2009;85:179-182. https://doi.org/10.1016/j.diabres.2009.04.028
- Jain RB. Perfluoroalkyl acids and their isomers, diabetes, anemia, and albuminuria: variabilities with deteriorating kidney function. Ecotoxicol Environ Saf. 2021;208:111625. https://doi.org/10.1016/j.ecoenv.2020.111625
- Yang JQ, Ran P, Chen JY, He YT, Li LW, Tan N, et al. Development of contrast-induced acute kidney injury after elective contrast media exposure in patients with type 2 diabetes mellitus: effect of albuminuria. PLoS One. 2014;9:e106454. https://doi.org/10.1371/journal.pone.0106454
- Okada H, Hasegawa G, Tanaka M, Osaka T, Shiotsu Y, Narumiya H, et al. Association between hemoglobin concentration and the progression or development of albuminuria in diabetic kidney disease. PLoS One. 2015;10:e0129192. https://doi.org/10.1371/journal.pone.0129192
- Yoon H, Go JS, Kim KU, Lee KW. The association of serum ferritin and metabolic syndrome and metabolic syndrome score in Korean adults. Korean J Clin Lab Sci. 2016;48:287-295. https://doi.org/10.15324/kjcls.2016.48.4.287
- Yoon H, Jeong DK, Lee KS, Kim HS, Moon AE, Park J. Relationship between metabolic syndrome and metabolic syndrome score and beta cell function by gender in Korean populations with obesity. Endocr J. 2016;63:785-793. https://doi.org/10.1507/endocrj.EJ16-0106
- Seong JM, Lee JH, Gi MY, Son YH, Moon AE, Park CE, et al. Gender difference in the association of chronic kidney disease with visceral adiposity index and lipid accumulation product index in Korean adults: Korean National Health and Nutrition Examination Survey. Int Urol Nephrol. 2021;53:1417-1425. https://doi.org/10.1007/s11255-020-02735-0
- Park J, Ryu SY, Han MA, Choi SW. The association of vitamin D with estimated glomerular filtration rate and albuminuria: 5th Korean National Health and Nutritional Examination Survey 2011-2012. J Ren Nutr. 2016;26:360-366. https://doi.org/10.1053/j.jrn.2016.07.003
- World Health Organization. Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers. World Health Organization: 2001.
- McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, Tang KL, et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin. 2004;20:1501-1510. https://doi.org/10.1185/030079904X2763
- Ryu SR, Park SK, Jung JY, Kim YH, Oh YK, Yoo TH, et al. The prevalence and management of anemia in chronic kidney disease patients: result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). J Korean Med Sci. 2017;32:249-256. https://doi.org/10.3346/jkms.2017.32.2.249
- Guedes M, Muenz DG, Zee J, Bieber B, Stengel B, Massy ZA, et al. Serum biomarkers of iron stores are associated with increased risk of all-cause mortality and cardiovascular events in nondialysis CKD patients, with or without anemia. J Am Soc Nephrol. 2021;32:2020-2030. https://doi.org/10.1681/ASN.2020101531
- Jankowski J, Floege J, Fliser D, Bohm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143:1157-1172. https://doi.org/10.1161/CIRCULATIONAHA.120.050686
- Hanna RM, Streja E, Kalantar-Zadeh K. Burden of anemia in chronic kidney disease: beyond erythropoietin. Adv Ther. 2021;38:52-75. https://doi.org/10.1007/s12325-020-01524-6
- Gouva C, Nikolopoulos P, Ioannidis JP, Siamopoulos KC. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int. 2004;66:753-760. https://doi.org/10.1111/j.1523-1755.2004.00797.x
- Srinivasan R, Fredy IC, Chandrashekar S, Saravanan J, Mohanta GP, Manna PK. Assessment of erythropoietin for treatment of anemia in chronic kidney failure- ESRD patients. Biomed Pharmacother. 2016;82:44-48. https://doi.org/10.1016/j.biopha.2016.04.041
- Babitt JL, Lin HY. Mechanisms of anemia in CKD. J Am Soc Nephrol. 2012;23:1631-1634. https://doi.org/10.1681/ASN.2011111078
- Han JS, Lee MJ, Park KS, Han SH, Yoo TH, Oh KH, et al. Albuminuria as a risk factor for anemia in chronic kidney disease: result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). PLoS One. 2015;10:e0139747. https://doi.org/10.1371/journal.pone.0139747
- Ritz E, Haxsen V. Diabetic nephropathy and anaemia. Eur J Clin Invest. 2005;35(Suppl 3):66-74. https://doi.org/10.1111/j.1365-2362.2005.01544.x
- Mutter S, Valo E, Aittomaki V, Nybo K, Raivonen L, Thorn LM, et al. Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes. Diabetologia. 2022;65:140-149. https://doi.org/10.1007/s00125-021-05584-3
- Maric C, Hall JE. Obesity, metabolic syndrome and diabetic nephropathy. Contrib Nephrol. 2011;170:28-35. https://doi.org/10.1159/000324941
- Dronavalli S, Duka I, Bakris GL. The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab. 2008;4:444-452. https://doi.org/10.1038/ncpendmet0894
- Lim AKh. Diabetic nephropathy - complications and treatment. Int J Nephrol Renovasc Dis. 2014;7:361-381. https://doi.org/10.2147/IJNRD.S40172
- Duran-Perez EG, Almeda-Valdes P, Cuevas-Ramos D, Campos-Barrera E, Munoz-Hernandez L, Gomez-Perez FJ. Treatment of metabolic syndrome slows progression of diabetic nephropathy. Metab Syndr Relat Disord. 2011;9:483-489. https://doi.org/10.1089/met.2011.0056
- Prinsen BHCMT, Velden MGMS, Kaysen GA, Straver HWHC, Rijn HJMV, Stellaard F, et al. Transferrin synthesis is increased in nephrotic patients insufficiently to replace urinary losses. J Am Soc Nephrol. 2001;12:1017-1025. https://doi.org/10.1681/ASN.V1251017
- Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607. https://doi.org/10.2337/diab.37.12.1595
- Cao Y, Lin JH, Hammes HP, Zhang C. Cellular phenotypic transitions in diabetic nephropathy: an update. Front Pharmacol. 2022;13:1038073. https://doi.org/10.3389/fphar.2022.1038073
- Zhang Y, Zhu X, Huang X, Wei X, Zhao D, Jiang L, et al. Advances in understanding the effects of erythropoietin on renal fibrosis. Front Med (Lausanne). 2020;7:47. https://doi.org/10.3389/fmed.2020.00047
- McGill JB, Haller H, Roy-Chaudhury P, Cherrington A, Wada T, Wanner C, et al. Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria. BMJ Open Diabetes Res Care. 2022;10:e002806. https://doi.org/10.1136/bmjdrc-2022-002806
- Yamazaki T, Mimura I, Tanaka T, Nangaku M. Treatment of diabetic kidney disease: current and future. Diabetes Metab J. 2021;45:11-26. https://doi.org/10.4093/dmj.2020.0217